Aardvark Therapeutics, Inc. — Form D
Aardvark Therapeutics, Inc. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-15. The offering totals $85.0M, of which $85.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-05-15
- Form: D
- Accession: 0001774857-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $85.0M
- Amount sold: $85.0M
- Investors: 31
- Date of first sale: 2024-05-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-513397
Issuer
- Name: Aardvark Therapeutics, Inc.
- CIK: 0001774857
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 4747 Executive Drive, San Diego, CA, 92121
- Phone: 8582257696
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Jeffrey Chi | Director | San Diego, CA |
| Tien-Li Lee | Director | San Diego, CA |
| Victor Tong | Director | Houston, TX |
| Tien-Li Lee | Executive Officer | San Diego, CA |
| Nelson Sun | Executive Officer | San Diego, CA |
| Henry Ji | Director | Palo Alto, CA |
| Jerel Banks | Director | Hayward, CA |
| Zachary Hornby | Director | San Diego, CA |
| Bob Shin | Director | San Diego, CA |
Other filings by this issuer (2)
More